|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 51/10 | |
| A61K 39/00 | |||
| A61K 47/68 | |||
| C07K 16/28 | |||
| C07K 16/30 | |||
| C12N 15/115 |
| (11) | Patento numeris | 3020730 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15197139.7 |
| Europos patento paraiškos padavimo data | 2012-01-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161434040 P | 2011-01-19 | US |
| (72) |
Fioretos, Thoas, SE
Järås, Marcus, SE
|
| (73) |
Cantargia AB,
Medicon Village Scheelevägen 2, 223 81 Lund,
SE
|
| (54) | ANTI-IL1RAP ANTIBODIES AND THEIR USE FOR TREATING SOLID TUMOURS |
| ANTI-IL1RAP ANTIBODIES AND THEIR USE FOR TREATING SOLID TUMOURS |